70 related articles for article (PubMed ID: 4618655)
1. Survival of canine renal allografts after treatment with polyspecific F(ab')2 fragments.
Abouna GM; Garver FA; Kogure H; DeLong TG; Andres GA
Surg Forum; 1973; 24():318-20. PubMed ID: 4618655
[No Abstract] [Full Text] [Related]
2. Control of humoral rejection of renal allografts in presensitized monkeys by monospecific F(ab')2 fragments.
Kahan MG; Martins AC; Macpherson SG; Wren SF; Busch GJ; Wilson RE
Surg Forum; 1975; 26():311-3. PubMed ID: 814638
[No Abstract] [Full Text] [Related]
3. In vitro and in vivo immunological effects of polyspecific F(ab')2 fragments in dogs.
Wren SF; Koppenheffer TL; Martins AC; Shaipanich T; von Haefen U; Busch GJ; Wilson RE
Surg Forum; 1973; 24():336-8. PubMed ID: 4806018
[No Abstract] [Full Text] [Related]
4. Passive enhancement of canine renal allografts with polyspecific F(ab')2 fragments.
Wren SF; Martins AC; Von Haefen U; Busch GJ; Katske GE; Koppenheffer TL; Shaipanich T; Wilson RE
Surgery; 1974 Jul; 76(1):112-20. PubMed ID: 4135410
[No Abstract] [Full Text] [Related]
5. Evaluation of organ specificity in renal allograft enhancement with F(ab') 2 fragments.
Shaipanich T; Wren S; von Haefen U; Koppenheffer T; Busch G; Wilson RE
Transplant Proc; 1973 Mar; 5(1):581-3. PubMed ID: 4572116
[No Abstract] [Full Text] [Related]
6. A clinical attempt to avoid hyperacute rejection by F (ab') 2 organ pretreatment.
Ahlmén J; Gustafsson A; Claes G; Kaijser B; Svalander C; Gelin L
Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):51-2. PubMed ID: 781817
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of hyperacute active rejection of renal allografts in primates using F(ab')2 and adequate immunosuppression].
Martins AC; Wren SF; Busch GJ; MacPherson SG; von Haefen U; Wilson RE
AMB Rev Assoc Med Bras; 1975 Sep; 21(9):259-64. PubMed ID: 1103241
[No Abstract] [Full Text] [Related]
8. The renal xenograft rejection. Effect of hyperimmune F(ab') 2 and succinylated IgG.
Habal MB; Misra MK; Busch GJ; Carpenter CB; Birtch AG
Transplantation; 1972 Dec; 14(6):796-8. PubMed ID: 4566275
[No Abstract] [Full Text] [Related]
9. Passive enhancement of cadaver renal allografts: a prospective randomized trial of F(ab')2 therapy.
Wilson RE; Garovoy MR; Strom TB; Lowry RP; Busch GJ; Vineyard GC; Tilney NL
Transplant Proc; 1981 Mar; 13(1 Pt 1):531-2. PubMed ID: 7022888
[No Abstract] [Full Text] [Related]
10. The protective effect of F(ab') 2 and succinylated IgG in the early treatment of hyperacute rejection in the primate.
Habal MB; Carpenter CB; Kobayashi K; Bush GJ; Misra M; Birtch AG
Transplant Proc; 1973 Mar; 5(1):601-6. PubMed ID: 4633093
[No Abstract] [Full Text] [Related]
11. Hyperimmune F(ab') 2 antibody: role in canine hyperacute renal allograft rejection.
Habal MB; Kobayashi K; Busch GJ; Birtch AG
J Surg Res; 1972 Nov; 13(5):228-31. PubMed ID: 4117988
[No Abstract] [Full Text] [Related]
12. Preliminary results with passive enhancement in human kidney transplantation.
Solheim BG; Flatmark A; Thorsby E
Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):53-8. PubMed ID: 781818
[TBL] [Abstract][Full Text] [Related]
13. Abrogation of hyperacute rejection of renal allografts by pepsin digest fragments of antidonor antibody.
Holter AR; McKearn TJ; Neu MR; Stuart FP
Surg Forum; 1972; 23(0):280-1. PubMed ID: 4601088
[No Abstract] [Full Text] [Related]
14. Abrogation of hyperacute rejection of renal allografts by pepsin digest fragments of antidonor antibody.
Holter AR; Neu MR; McKearn TJ; Lynch AF; Stuart FP
Transplant Proc; 1973 Mar; 5(1):593-6. PubMed ID: 4121180
[No Abstract] [Full Text] [Related]
15. Hyperacute rejection of renal allografts in the primate: protective effect of F(ab') 2 fragment of hyperimmune serum.
Kobayashi K; Hricko GM; Habal MB; Lukl P; Busch GJ; Hunsicker L; Reisner GS; Birtch AG
Transplantation; 1972 Sep; 14(3):374-81. PubMed ID: 4629283
[No Abstract] [Full Text] [Related]
16. Enhancement of canine renal allografts. II. Studies with Fab fragments.
Martin DC; Blackwelder R; Rasband R; Morton ME
Trans Am Assoc Genitourin Surg; 1976; 68():99-101. PubMed ID: 801216
[No Abstract] [Full Text] [Related]
17. Prolonged survival of renal allografts in outbred rabbits treated with donor specific F(ab')2 alloantibody.
Sutherland DE; Howard RJ; Dombrovskis S; Najarian JS
Ann Surg; 1974 Dec; 180(6):857-63. PubMed ID: 4611361
[TBL] [Abstract][Full Text] [Related]
18. Soluble RNA-treated autogeneic lymphocytes. Effect on canine renal allografts.
Hamby WM; Schaaff DM; Canning JR
Transplantation; 1971 Jun; 11(6):575-8. PubMed ID: 4931458
[No Abstract] [Full Text] [Related]
19. Renal allograft prolongation after graft perfusion with heterologous antilymphocyte globulin.
Callender CO; Santiago EA; Sutherland D; Howard RJ; Toledo-Pereya LH; Olson L; Condie R; Simmons RL; Najarian JS
Surg Forum; 1973; 24():306-8. PubMed ID: 4618654
[No Abstract] [Full Text] [Related]
20. Purification of antibody Fab and F(ab')2 fragments using Gradiflow technology.
Cheung GL; Thomas TM; Rylatt DB
Protein Expr Purif; 2003 Nov; 32(1):135-40. PubMed ID: 14680950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
